Have a personal or library account? Click to login
Usefulness of f-18 FDG PET/CT in subcutaneous panniculitis-like t cell lymphoma: disease extent and treatment response evaluation Cover

Usefulness of f-18 FDG PET/CT in subcutaneous panniculitis-like t cell lymphoma: disease extent and treatment response evaluation

Open Access
|Nov 2012

References

  1. 1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHOEORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85.10.1182/blood-2004-09-350215692063
  2. 2. Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991; 15: 17-27.10.1097/00000478-199101000-000021985499
  3. 3. Horvat M, Jezersek Novakovic B. Effect of response quality and line of treatment with rituximab on overall and disease-free survival of patients with B-cell lymphoma. Radiol Oncol 2010; 44: 232-8.10.2478/v10019-010-0044-6342370322933921
  4. 4. Salhany KE, Macon WR, Choi JK, Elenitsas R, Lessin SR, Felgar RE, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 1998; 22: 881-93.10.1097/00000478-199807000-000109669350
  5. 5. Paulli M, Berti E. Cutaneous T-cell lymphomas (including rare subtypes): current concepts II. Haematologica 2004; 89:1371-2.
  6. 6. Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 2008; 111: 838-45.10.1182/blood-2007-04-08728817934071
  7. 7. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL: Harrison’s principles of internal medicine. New York: McGraw-Hill; 2005. p. 654.
  8. 8. Weenig RH, Ng CS, Perniciaro C. Subcutaneous panniculitis-like T-cell lymphoma. Am J Dermatopathol 2001; 23: 206-15.10.1097/00000372-200106000-0000811391101
  9. 9. Hoque SR, Child FJ, Whittaker SJ, Ferreira S, Orchard G, Jenner K, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol 2003; 148: 516-25.10.1046/j.1365-2133.2003.05226.x12653744
  10. 10. Marzano AV, Berti E, Paulli M, Caputo R. Cytophagocytic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma. Arch Dermatol 2000; 136: 889-96.10.1001/archderm.136.7.88910890991
  11. 11. Perniciaro C, Zalla MJ, White JW Jr, Menke DM. Subcutaneous T-cell lymphoma. Report of two additional cases and further observations. Arch Dermatol. 1993, 129: 1171-6.10.1001/archderm.129.9.11718363403
  12. 12. Takeshita M, Imayama S, Oshiro Y, Kurihara K, Okamoto S, Matsuki Y, et al. Clinicopathologic analysis of 22 cases of subcutaneous panniculitis-like CD56- or CD56+ lymphoma and review of 44 other reported cases. Am J Clin Pathol 2004; 121: 408-16.10.1309/TYRGT196N2APLLR9
  13. 13. Massone C, Chott A, Metze D, Kerl K, Citarella L, Vale E, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic and molecular study of 50 patients. Am J Surg Pathol 2004; 28: 719-35.10.1097/01.pas.0000126719.71954.4f15166664
  14. 14. Lee HJ, Im JG, Goo JM, Kim KW, Choi BI, Chang KH, et al. Peripheral T-Cell lymphoma: spectrum of imaging findings with clinical and pathologic features. RadioGraphics 2003; 23: 7-26.10.1148/rg.23102501812533636
  15. 15. Kang BS, Choi SH, Cha HJ, Jung YK, Lee JH, Jeong AK, et al. Subcutaneous panniculitis-like T-cell lymphoma: US and CT findings in three patients. Skeletal Radiol 2007; 36: S67-71.10.1007/s00256-006-0173-616909278
  16. 16. Hodolic M. Role of 18F-choline PET/CT in evaluation of patients with prostate carcinoma. Radiol Oncol 2011; 45: 17-21.10.2478/v10019-010-0050-8342371422933929
  17. 17. Huić D, Mutvar A, Kinda-Bašić S, Aurer T, Ciglar1M, Grošev D, et al. Negative predictive value of F-18-FDG coincidence PET in patients with Hodgkin’s disease and a residual mass after therapy: a retrospective diagnostic test study. Radiol Oncol 2009; 43: 258-63.10.2478/v10019-009-0024-x
  18. 18. Jerusalem G, Hustinx R, Beguin Y, Fillet G. Evaluation of therapy for lymphoma. Semin Nucl Med 2005; 35: 186-96.10.1053/j.semnuclmed.2005.02.00416098292
  19. 19. Ravizzini G, Meirelles GS, Horwitz SM, Grewal RK. F-18 FDG uptake in subcutaneous panniculitis-like T-cell lymphoma. Clin Nucl Med 2008; 33: 903-5.10.1097/RLU.0b013e31818bf2c719033805
  20. 20. Kong EJ, Cho IH, Chun KA, Bae YK, Chol JH, Hyun MS. F-18 FDG PET/CT findings of subcutaneous panniculitis-like T-cell lymphoma: a case report. Nucl Med Mol Imaging 2009; 43: 240-4.
  21. 21. Tsai EY, Taur A, Espinosa L, Quon A, Johnson D, Dick S, et al. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol 2006; 142: 577-84.10.1001/archderm.142.5.57716702495
  22. 22. Kuo PH, McClennan BL, Carlson K, Wilson LD, Edelson RL, Heald PW, et al. FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma. Mol Imaging Biol 2008; 10: 74-81.10.1007/s11307-007-0127-y18196347
  23. 23. Rodriguez VR, Joshi A, Peng F, Rabah RM, Stockmann PT, Savaşan S. Positron emission tomography in subcutaneous panniculitis-like T-cell lymphoma. Pediatr Blood Cancer 2009; 52: 406-8.10.1002/pbc.2180518985722
DOI: https://doi.org/10.2478/v10019-012-0017-z | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 279 - 283
Submitted on: Dec 30, 2011
|
Accepted on: Jan 21, 2012
|
Published on: Nov 9, 2012
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Jin-Suk Kim, Young Jin Jeong, Myung-Hee Sohn, Hwan-Jeong Jeong, Seok Tae Lim, Dong Wook Kim, Jae-Yong Kwak, Chang-Yeol Yim, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.